Finance

Lists
DVAI34:BVMF
Davita Inc BDR
R$ ८९३.५६
०.००%
(०.००) 1D
अक्टोबर ९, १६:५६:०० GMT-३  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DVAI34...
Open
R$ ८९३.५६
High
R$ ८९३.५६
Low
R$ ८९३.५६
Mkt. cap
११.४४ अरब
Avg. vol.
७.००
Volume
१.००
52-wk high
R$ १,२५३.२६
52-wk low
R$ ५४६.६३
Shares outstanding
६.३८ करोड
No. of employees
७८ हजार
Open
R$ ८९३.५६
High
R$ ८९३.५६
Low
R$ ८९३.५६
Mkt. cap
११.४४ अरब
Avg. vol.
७.००
Volume
१.००
52-wk high
R$ १,२५३.२६
52-wk low
R$ ५४६.६३
Shares outstanding
६.३८ करोड
No. of employees
७८ हजार
News stories
From web sources and news partners
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc BDR
CEOJavier J. Rodriguez
Employees७८ हजार
Founded१९९२
Headquartersडेन्वर, कोलोराडो, संयुक्त राज्य अमेरिका
Sector-
Websitedavita.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
३.४२ अरब
३.६२ अरब
३.४२ अरब
३.५५ अरब
Cost of goods sold
२.३३ अरब
२.४१ अरब
२.३४ अरब
२.३९ अरब
Cost of revenue
२.३३ अरब
२.४१ अरब
२.३४ अरब
२.३९ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४०.२७ करोड
४७.२४ करोड
४२.१९ करोड
४२.३५ करोड
Operating expense
५८.०२ करोड
६५.९१ करोड
५९.९७ करोड
५९.१३ करोड
Total operating expenses
२.९१ अरब
३.०७ अरब
२.९४ अरब
२.९८ अरब
Operating income
५०.७३ करोड
५५.१२ करोड
४७.३५ करोड
५७.०८ करोड
Other non operating income
-१.७३ करोड
-२.१० करोड
६.३९ लाख
४४.६६ लाख
EBT including unusual items
३०.८८ करोड
३८.२८ करोड
३४.१२ करोड
४३.५० करोड
EBT excluding unusual items
३५.१६ करोड
३९.१८ करोड
३४.१२ करोड
४३.७० करोड
Income tax expense
६.८६ करोड
७.६७ करोड
६.६२ करोड
९.१८ करोड
Effective tax rate
२२.२०%
२०.०५%
१९.४०%
२१.१०%
Other operating expenses
-
-
-
-
Net income
१५.०३ करोड
२३.४२ करोड
१९.७५ करोड
२६.५४ करोड
Net profit margin
४.४०%
६.४७%
५.७८%
७.४७%
Earnings per share
२.५१
३.४०
२.८७
४.०२
Interest and investment income
-
-
-
-
Interest expense
-१४.८७ करोड
-१४.८३ करोड
-१४.१३ करोड
-१४.६४ करोड
Net interest expenses
-१४.८७ करोड
-१४.८३ करोड
-१४.१३ करोड
-१४.६४ करोड
Depreciation and amortization charges
१७.७५ करोड
१८.६७ करोड
१७.७८ करोड
१६.७८ करोड
EBITDA
६८.४८ करोड
७३.७९ करोड
६५.१४ करोड
७३.८६ करोड
Gain or loss from assets sale
-
-१.७५ करोड
-
-
AI content may include mistakes. Learn more
Google एपहरू